CN106418398A - 一种治疗糖尿病的食品 - Google Patents
一种治疗糖尿病的食品 Download PDFInfo
- Publication number
- CN106418398A CN106418398A CN201610740609.1A CN201610740609A CN106418398A CN 106418398 A CN106418398 A CN 106418398A CN 201610740609 A CN201610740609 A CN 201610740609A CN 106418398 A CN106418398 A CN 106418398A
- Authority
- CN
- China
- Prior art keywords
- grams
- food
- diabetes
- gram
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 33
- 235000013305 food Nutrition 0.000 title claims abstract description 27
- 244000045195 Cicer arietinum Species 0.000 claims abstract description 10
- 235000010523 Cicer arietinum Nutrition 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 10
- 241000209140 Triticum Species 0.000 claims abstract description 10
- 235000021307 Triticum Nutrition 0.000 claims abstract description 10
- 229940089161 ginsenoside Drugs 0.000 claims abstract description 10
- 229930182494 ginsenoside Natural products 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 9
- 229920002498 Beta-glucan Polymers 0.000 claims description 9
- 210000001161 mammalian embryo Anatomy 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 16
- 239000003814 drug Substances 0.000 abstract description 15
- 102000004877 Insulin Human genes 0.000 abstract description 8
- 108090001061 Insulin Proteins 0.000 abstract description 8
- 229940125396 insulin Drugs 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 210000004153 islets of langerhan Anatomy 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 3
- 210000003719 b-lymphocyte Anatomy 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 abstract description 2
- 230000003915 cell function Effects 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 229920001503 Glucan Polymers 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 241000229143 Hippophae Species 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 229940127003 anti-diabetic drug Drugs 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 235000020980 bad eating habits Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆30‑40克,沙棘5‑10克,山药10‑20克,桑叶20‑30克,小麦胚芽20‑30克,燕麦葡聚糖10‑20克,人参皂苷5‑10克,本发明立足于中医标本兼制的原则,对糖尿病在采用传统降糖疗法的基础上,通过大量的临床试验,在治疗糖尿病方面具有提高人体免疫力,健脾益胃,降低血糖的功效,服用后,不仅血糖、尿糖得到有效控制制,精力、体力等功能也会恢复的很好,能够激发自身细胞修复能力,激活胰岛细胞功能,修复胰岛B细胞,可以逐渐让人体停掉胰岛素西药,使身体各机能恢复健康。
Description
技术领域
本发明涉及一种食品,特别是涉及一种治疗糖尿病的食品。
背景技术
糖尿病是世界三大疑难病症之一,几十年来,世界各国纷纷进行了长期不懈的研究与开发。在治疗糖尿病历史上有过两次重大突破:第一次是20世纪50年代,中国首次人工合成胰岛素,震惊世界;第二次是双胍类及磺脲类口服降糖药的问世,使糖尿病患者的血糖得以暂时控制。目前用于临床治疗所用中西药已达数十种,但是由于对糖尿病病理、病因研究至今还没有实质性的突破,治疗糖尿病仍处于控制血糖、尿糖增高阶段和预防综合并发症的研究阶段。此外,患者长期服用西药,会对肾、肝、心、脾、胃等脏器带来副作用。国内新开发出来的各种纯中药制剂其药效也均处于控制血糖增高阶段,没有任何一种药物既能提高人体免疫力,又能健脾益胃,修复胰岛细胞,从根本上控制血糖。
发明内容
为解决以上问题,本发明提供一种治疗糖尿病的食品,既能提高人体免疫力,又能健脾益胃,修复胰岛细胞,可以从根本上控制血糖,让人体恢复健康。
为实现上述目的,本发明采用以下技术手段:
一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆30-40克,沙棘5-10克,山药10-20克,桑叶20-30克,小麦胚芽20-30克,燕麦葡聚糖10-20克,人参皂苷5-10克。
优选的,一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆33-38克,沙棘6-9克,山药12-18克,桑叶24-28克,小麦胚芽23-27克,燕麦葡聚糖11-16克,人参皂苷6-9克。
优选的,一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆36克,沙棘8克,山药15克,桑叶26克,小麦胚芽24克,燕麦葡聚糖14克,人参皂苷7克。
进一步的,所述一种治疗糖尿病的食品,采用现有中药制取方法,制成冲剂。
本发明的有益效果:
本发明立足于中医标本兼制的原则,对糖尿病在采用传统降糖疗法的基础上,通过大量的临床试验,在治疗糖尿病方面具有提高人体免疫力,健脾益胃,降低血糖的功效,服用后,不仅血糖、尿糖得到有效控制制,精力、体力等功能也会恢复的很好,能够激发自身细胞修复能力,激活胰岛细胞功能,修复胰岛B细胞,可以逐渐让人体停掉胰岛素西药,使身体各机能恢复健康。
具体实施方式
下面结合具体实施例对本发明做进一步说明。
实施例1:一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆30克,沙棘5克,山药10克,桑叶20克,小麦胚芽20克,燕麦葡聚糖10克,人参皂苷5克。
进一步的,所述一种治疗糖尿病的食品,采用现有中药制取方法,制成冲剂,方便服用。
张某,由于长期在商场的打拼,养成了很不好的饮食习惯,不久前查出患有糖尿病,血糖时常不稳定,一开始张先生选择的是使用胰岛素西药的治疗方法,但是西药的副作用较大,后来,张先生在服用本处方后20天后,停掉了胰岛素西药,又坚持服用了两个月,配合合理饮食,病情得到明显好转,血糖已经稳定,病情得到康复。
实施例2:一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆35克,沙棘8克,山药15克,桑叶25克,小麦胚芽25克,燕麦葡聚糖15克,人参皂苷8克。
进一步的,所述一种治疗糖尿病的食品,采用现有中药制取方法,制成冲剂,方便服用。
李某,患有糖尿病多年,血糖一直不平稳,试过吃降糖药,打胰岛素,可是效果都不是很好,容易反弹,且对身体具有一定的影响,后来在服用本处方药后,又配合合理饮食,身体的免疫力得到增强,血糖明显得到控制,身体恢复健康。
实施例3:一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆40克,沙棘10克,山药20克,桑叶30克,小麦胚芽30克,燕麦葡聚糖20克,人参皂苷10克。
进一步的,所述一种治疗糖尿病的食品,采用现有中药制取方法,制成冲剂,方便服用。
高某,患有糖尿病已经好多年,也持续治疗了多年,主要是以吃降糖药和打胰岛素为主,虽然经过一段时间,血糖能够得到一定降低,但是再隔一段时间后,血糖仍然会再次升高,如此反复,很是痛苦,而且每次降糖药和打胰岛素的剂量越来越大,否则血糖就降不下去,身体虚弱同时承受着莫大的痛苦,高女士在朋友的推荐下服用本处方,在持续服用了1个月后,药性作用开始明显,在服用2个月后,病情明显减轻,而且血糖的含量一直稳定下降,不会出现反复不稳的情况,现高女士仍然在服用中,她对完全痊愈,最终战胜病魔很有信心。
Claims (4)
1.一种治疗糖尿病的食品,其特征在于,其原料的组成及配比为:鹰嘴豆30-40克,沙棘5-10克,山药10-20克,桑叶20-30克,小麦胚芽20-30克,燕麦葡聚糖10-20克,人参皂苷5-10克。
2.根据权利要求1所述的一种治疗糖尿病的食品,其特征在于,其原料的组成及配比为:鹰嘴豆33-38克,沙棘6-9克,山药12-18克,桑叶24-28克,小麦胚芽23-27克,燕麦葡聚糖11-16克,人参皂苷6-9克。
3.根据权利要求1所述的一种治疗糖尿病的食品,其原料的组成及配比为:鹰嘴豆36克,沙棘8克,山药15克,桑叶26克,小麦胚芽24克,燕麦葡聚糖14克,人参皂苷7克。
4.根据权利要求1所述的一种治疗糖尿病的食品,其特征在于,所述一种治疗糖尿病的食品,制成冲剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610740609.1A CN106418398A (zh) | 2016-08-29 | 2016-08-29 | 一种治疗糖尿病的食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610740609.1A CN106418398A (zh) | 2016-08-29 | 2016-08-29 | 一种治疗糖尿病的食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106418398A true CN106418398A (zh) | 2017-02-22 |
Family
ID=58182350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610740609.1A Pending CN106418398A (zh) | 2016-08-29 | 2016-08-29 | 一种治疗糖尿病的食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106418398A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109430721A (zh) * | 2018-10-17 | 2019-03-08 | 广州市好孝心医疗器械有限公司 | 一种具有降血糖作用的小麦胚芽组合物及其制备方法 |
CN110839805A (zh) * | 2019-11-22 | 2020-02-28 | 坤承(北京)健康管理有限公司 | 一种植物固体饮料 |
CN111000119A (zh) * | 2019-09-19 | 2020-04-14 | 皈元(广州)健康文化传播有限公司 | 一种沙棘破壁燕麦粉及其生产工艺 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101094595A (zh) * | 2004-11-29 | 2007-12-26 | 美国芦荟株式会社 | 食物组合的脱水 |
CN102273621A (zh) * | 2010-06-09 | 2011-12-14 | 苏州润新生物科技有限公司 | 一种预防和治疗糖尿病的食品或保健食品 |
CN102599512A (zh) * | 2012-03-26 | 2012-07-25 | 中国科学院新疆理化技术研究所 | 一种沙棘营养粉及其制备方法 |
-
2016
- 2016-08-29 CN CN201610740609.1A patent/CN106418398A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101094595A (zh) * | 2004-11-29 | 2007-12-26 | 美国芦荟株式会社 | 食物组合的脱水 |
CN102273621A (zh) * | 2010-06-09 | 2011-12-14 | 苏州润新生物科技有限公司 | 一种预防和治疗糖尿病的食品或保健食品 |
CN102599512A (zh) * | 2012-03-26 | 2012-07-25 | 中国科学院新疆理化技术研究所 | 一种沙棘营养粉及其制备方法 |
Non-Patent Citations (7)
Title |
---|
徐峰编著: "《药茶药酒药膳对症疗方》", 30 November 2015, 广东科技出版社 * |
易磊 牛林敬编著: "《糖尿病怎么吃速查手册》", 30 September 2013, 上海科学技术文献出版社 * |
李成卫 主编: "《改变糖尿病100法》", 30 June 2009, 中国纺织出版社 * |
李良 著: "《糖尿病的中医治疗》", 30 April 1989, 光明日报出版社 * |
柴瑞霞主编: "《专家教你做养生家常菜:"三高"篇》", 30 June 2014, 新疆人民卫生出版社 * |
桑国卫等主编;中国药学会编: "《中国创新药物研发战略研究报告2014-2015》", 31 March 2016, 第四军医大学出版社 * |
植物草香 主编: "《食物是最好的医药》", 31 October 2009, 哈尔滨出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109430721A (zh) * | 2018-10-17 | 2019-03-08 | 广州市好孝心医疗器械有限公司 | 一种具有降血糖作用的小麦胚芽组合物及其制备方法 |
CN111000119A (zh) * | 2019-09-19 | 2020-04-14 | 皈元(广州)健康文化传播有限公司 | 一种沙棘破壁燕麦粉及其生产工艺 |
CN110839805A (zh) * | 2019-11-22 | 2020-02-28 | 坤承(北京)健康管理有限公司 | 一种植物固体饮料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106418398A (zh) | 一种治疗糖尿病的食品 | |
CN106721984A (zh) | 一种代餐平糖营养粉 | |
CN104605226A (zh) | 一种具有增加骨密度功能的保健品 | |
CN105943958A (zh) | 一种治疗痛风的桦褐孔菌复合固体颗粒及其制备方法 | |
CN103356697B (zh) | 一种干细胞制剂及其制备的口服液 | |
CN105969612A (zh) | 一种辣木籽保健酒 | |
CN109125591A (zh) | 一种治疗脓毒症心衰的中药组合物及其制备方法 | |
CN104824207A (zh) | 西洋参养生中药茶饮品及制备方法 | |
CN102000238A (zh) | 九龙胶囊及制备方法 | |
CN103599203A (zh) | 一种治疗颈椎病、腰椎间盘突出症、骨关节疾病的药酒 | |
CN102793870A (zh) | 一种治疗肾结石的中草药 | |
CN102512569A (zh) | 一种治疗小儿厌食的中药口服汤剂 | |
CN1686497A (zh) | 治疗性功能障碍、月经不调、不育症和增强免疫功能的中药制剂 | |
CN102552755A (zh) | 一种治疗再生障碍性贫血的中药组合物 | |
CN104623130A (zh) | 一种治疗眼睑下垂的内服药物及其制备方法 | |
CN106511946A (zh) | 一种治疗慢性肾小球性肾炎的中药及其制备方法 | |
CN103131611B (zh) | 一种预防颈椎病、腰间盘突出、肩周炎的含酒精饮料 | |
CN1053369C (zh) | 甲亢丸 | |
CN111643580B (zh) | 一种用于治疗视神经脊髓炎的中药组合物 | |
CN109200195A (zh) | 一种治疗糖尿病的中药组合物及其应用和装置 | |
CN106620117A (zh) | 一种治疗肠胃炎的中成药及其制备方法 | |
CN106509628A (zh) | 一种治疗糖尿病食疗干预的方剂 | |
CN105395650A (zh) | 舒肝宁制剂在制备治疗骨质疏松及其并发症药物中的应用 | |
CN107625863A (zh) | 治疗风湿骨病的复方中药软胶囊及其制备方法 | |
CN102416112B (zh) | 一种治疗消渴病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |
|
RJ01 | Rejection of invention patent application after publication |